Published in Epidemiology on September 01, 2011
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10
A claims data-based comparison of comorbidity in individuals with and without dementia. BMC Geriatr (2014) 1.58
Alzheimer disease and cancer risk: a meta-analysis. J Cancer Res Clin Oncol (2014) 1.44
Slaying dementia dragons with blood, lungs, and guts. J Am Geriatr Soc (2013) 1.39
High blood pressure and cognitive decline in mild cognitive impairment. J Am Geriatr Soc (2013) 1.09
Blood pressure and cognition: factors that may account for their inconsistent association. Epidemiology (2013) 1.01
A self-report risk index to predict occurrence of dementia in three independent cohorts of older adults: the ANU-ADRI. PLoS One (2014) 1.00
Biased Exposure-Health Effect Estimates from Selection in Cohort Studies: Are Environmental Studies at Particular Risk? Environ Health Perspect (2015) 0.98
Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study. PLoS Med (2015) 0.97
Development of a new method for assessing global risk of Alzheimer's disease for use in population health approaches to prevention. Prev Sci (2013) 0.97
Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimers Dement (2014) 0.93
Guidelines for reporting methodological challenges and evaluating potential bias in dementia research. Alzheimers Dement (2015) 0.91
20-Year prevalence projections for dementia and impact of preventive policy about risk factors. Eur J Epidemiol (2013) 0.87
Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension (2016) 0.87
Cardiovascular risk score, cognitive decline, and dementia in older Mexican Americans: the role of sex and education. J Am Heart Assoc (2013) 0.86
Hypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the Future. Am J Hypertens (2015) 0.86
Hypertension and aging. Ageing Res Rev (2016) 0.84
Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'. Neurodegener Dis Manag (2015) 0.83
The association of diabetes and dementia and possible implications for nondiabetic populations. Expert Rev Neurother (2011) 0.82
Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study. Alzheimers Dement (2017) 0.80
What is the role of modifiable environmental and lifestyle risk factors in young onset dementia? Eur J Epidemiol (2015) 0.78
Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention. Transl Psychiatry (2012) 0.77
Independent and interactive impacts of hypertension and diabetes mellitus on verbal memory: A coordinated analysis of longitudinal data from England, Sweden, and the United States. Psychol Aging (2016) 0.77
The Test Your Memory cognitive screening tool: sociodemographic and cardiometabolic risk correlates in a population-based study of older British men. Int J Geriatr Psychiatry (2015) 0.77
Blood Pressure and Risk of Vascular Dementia: Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke. Stroke (2016) 0.77
Neuropathological diagnoses and clinical correlates in older adults in Brazil: A cross-sectional study. PLoS Med (2017) 0.76
Bridging the Translation Gap: From Dementia Risk Assessment to Advice on Risk Reduction. J Prev Alzheimers Dis (2015) 0.76
Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders. J Alzheimers Dis (2016) 0.76
Population attributable fraction of modifiable risk factors for Alzheimer disease: A systematic review of systematic reviews. Iran J Neurol (2016) 0.76
[Effects of long-term antihypertensive therapy with losartan on blood pressure and cognitive function in patients with essential hypertension and other cerebrovascular risk factors (AWARE observational study)]. Med Klin (Munich) (2008) 0.75
Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine. Evid Based Complement Alternat Med (2016) 0.75
Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis. Alzheimers Dement (Amst) (2017) 0.75
Neurocardiovascular Instability and Cognition. Yale J Biol Med (2016) 0.75
Life-course blood pressure in relation to brain volumes. Alzheimers Dement (2016) 0.75
Cumulative systolic blood pressure exposure in relation to cognitive function in middle-aged and elderly adults: A prospective, population-based study. Medicine (Baltimore) (2016) 0.75
The Influence of Vascular Risk Factors and Stroke on Cognition in Late Life: Analysis of the NACC Cohort. Alzheimer Dis Assoc Disord (2015) 0.75
Intima-Media Thickness and Cognitive Function in Stroke-Free Middle-Aged Adults: Findings From the Coronary Artery Risk Development in Young Adults Study. Stroke (2015) 0.75
Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction. J Mol Psychiatry (2015) 0.75
Hypertension and Alzheimer disease: is there a link? Epidemiology (2012) 0.75
Cognitive Function and Vascular Risk Factors Among Older African American Adults. J Immigr Minor Health (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
A structural approach to selection bias. Epidemiology (2004) 16.44
Identifiability and exchangeability for direct and indirect effects. Epidemiology (1992) 14.88
Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA (2003) 14.77
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology (2007) 9.27
Cerebral blood flow in dementia. Arch Neurol (1975) 9.24
Fallibility in estimating direct effects. Int J Epidemiol (2002) 8.34
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42
Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension (1995) 6.48
15-year longitudinal study of blood pressure and dementia. Lancet (1996) 6.44
Quantifying biases in causal models: classical confounding vs collider-stratification bias. Epidemiology (2003) 6.35
The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol (2005) 4.54
Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging (2000) 4.22
Selection of controls in case-control studies. I. Principles. Am J Epidemiol (1992) 3.94
Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol (2002) 3.85
Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology (2008) 3.76
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology (2004) 3.61
Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain (2005) 3.34
Measuring cognitive function with age: the influence of selection by health and survival. Epidemiology (2008) 3.19
Cerebral white matter lesions and the risk of dementia. Arch Neurol (2004) 3.17
A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies. J Clin Epidemiol (2005) 3.04
Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke (2002) 3.00
Vascular risk factors and dementia: how to move forward? Neurology (2009) 2.97
Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med (2006) 2.90
Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol (1998) 2.77
Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging (2000) 2.77
Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry (2009) 2.57
Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension (2004) 2.43
Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med (2002) 2.41
Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study. Neurology (2007) 2.40
Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. Arch Intern Med (2001) 2.36
Hypertension and cerebral white matter lesions in a prospective cohort study. Brain (2002) 2.31
Low blood pressure and the risk of dementia in very old individuals. Neurology (2003) 2.30
Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry (2008) 2.26
Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging (2000) 2.26
Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag (2008) 2.13
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet (1999) 2.11
Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Intern Med (2001) 2.01
Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. Int J Epidemiol (2001) 1.98
Attrition and bias in the MRC cognitive function and ageing study: an epidemiological investigation. BMC Public Health (2004) 1.97
Cigarette smoking and dementia: potential selection bias in the elderly. Epidemiology (2008) 1.90
Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord (2006) 1.85
Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons. Neurology (2009) 1.78
Cognitive impairment and mortality in the community-dwelling elderly. Am J Epidemiol (2000) 1.78
Cardiovascular disease and Alzheimer's disease: common links. J Intern Med (2006) 1.74
Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol (2002) 1.70
Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci U S A (2000) 1.66
Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature. Alzheimer Dis Assoc Disord (2009) 1.64
Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology (2005) 1.59
Cerebral microhemorrhage. Stroke (2006) 1.58
Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation (2010) 1.57
Alzheimer disease and mortality: a 15-year epidemiological study. Arch Neurol (2005) 1.55
Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care (2008) 1.52
Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke (2003) 1.42
Blood pressure and the risk for dementia: a double edged sword. Ageing Res Rev (2008) 1.40
Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke (2000) 1.29
Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci (1995) 1.29
Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure. J Neurol (2007) 1.28
Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project. Eur J Cardiovasc Prev Rehabil (2006) 1.27
ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord (2010) 1.26
Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord (2001) 1.23
Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol (2001) 1.22
The reproducibility of average ambulatory, home, and clinic pressures. Hypertension (1988) 1.21
Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke (1996) 1.17
Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study. J Am Geriatr Soc (2007) 1.16
Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord (2007) 1.16
Expression and distribution of beta amyloid precursor protein and beta amyloid peptide in reactive astrocytes after transient middle cerebral artery occlusion. Acta Neurochir (Wien) (2001) 1.14
Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res (2000) 1.13
Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure. Neurology (1998) 1.11
Cortical neuronal apoptosis in CADASIL. Stroke (2006) 1.11
Decline in blood pressure over time and risk of dementia: a longitudinal study from the Kungsholmen project. Stroke (2004) 1.07
Microarray analysis of hippocampal gene expression in global cerebral ischemia. Ann Neurol (2001) 1.06
Mixed dementia: epidemiology, diagnosis, and treatment. J Am Geriatr Soc (2002) 1.03
Risk factors for incident Alzheimer's disease in African Americans and Yoruba. Metab Brain Dis (2006) 1.00
Midlife risk factors for subtypes of dementia: a nested case-control study in Taiwan. Am J Geriatr Psychiatry (2007) 0.97
A population-based study on blood pressure and brain atrophy in 85-year-olds. Hypertension (1998) 0.95
Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc (2010) 0.94
The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia. Psychiatry Res (2010) 0.93
Blood pressure variability and ambulatory monitoring. Curr Opin Nephrol Hypertens (1993) 0.88
Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease. Ann N Y Acad Sci (2002) 0.88
Spatial resolution of the primary beta-amyloidogenic process induced in postischemic hippocampus. J Biol Chem (1994) 0.88
Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons. Neuroepidemiology (2005) 0.87
Cerebral atrophy in cerebrovascular disorders. J Neuroimaging (2009) 0.86
Risk factors for lacunar stroke: a case-control transesophageal echocardiographic study. Neurology (2000) 0.85
Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment. Neurol Res (2010) 0.79
SPECT imaging of GABA(A)/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment. Eur J Nucl Med Mol Imaging (2010) 0.78
Vascular cognitive impairment: dementia biology and translational animal models. Curr Opin Investig Drugs (2009) 0.78
Risk of incident dementia in drug-untreated arterial hypertension: a population-based study. J Alzheimers Dis (2010) 0.78
[The incidence of dementia among elderly people in Xi' an, China]. Zhonghua Liu Xing Bing Xue Za Zhi (2005) 0.77
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52
A common genetic variant is associated with adult and childhood obesity. Science (2006) 14.95
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet (2007) 12.13
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet (2008) 6.71
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol (2009) 6.02
Genomic screening and replication using the same data set in family-based association testing. Nat Genet (2005) 5.44
The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex (2008) 5.36
Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol (2004) 4.89
Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology (2013) 4.80
Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet (2008) 4.66
When is baseline adjustment useful in analyses of change? An example with education and cognitive change. Am J Epidemiol (2005) 4.54
Family-based association between Alzheimer's disease and variants in UBQLN1. N Engl J Med (2005) 4.34
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet (2012) 4.27
Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci (2006) 4.14
Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med (2009) 3.73
Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet (2005) 3.24
Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect (2008) 3.17
Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol (2005) 3.10
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol (2010) 2.91
Navigation with electromagnetic tracking for interventional radiology procedures: a feasibility study. J Vasc Interv Radiol (2005) 2.67
Psychiatric genetics: a survey of psychiatrists' knowledge, opinions, and practice patterns. J Clin Psychiatry (2005) 2.46
Genomewide weighted hypothesis testing in family-based association studies, with an application to a 100K scan. Am J Hum Genet (2007) 2.45
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol (2010) 2.31
Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality. Neurocrit Care (2012) 2.25
The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biol Psychiatry (2007) 2.19
Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation (2011) 2.17
Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke (2008) 2.12
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy. J Vasc Interv Radiol (2007) 2.00
Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med (2008) 1.98
Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. Arch Neurol (2008) 1.92
Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage. Stroke (2012) 1.89
Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry (2007) 1.88
Microbleeds versus macrobleeds: evidence for distinct entities. Stroke (2009) 1.83
American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry (2007) 1.79
Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study. Ann Intern Med (2014) 1.78
Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol (2011) 1.77
Dietary sodium restriction reverses vascular endothelial dysfunction in middle-aged/older adults with moderately elevated systolic blood pressure. J Am Coll Cardiol (2012) 1.77
Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol (2008) 1.74
Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs (2010) 1.67
Development of a comorbidity index for use in obstetric patients. Obstet Gynecol (2013) 1.65
The status of telestroke in the United States: a survey of currently active stroke telemedicine programs. Stroke (2012) 1.65
Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol (2008) 1.60
Feasibility of multi-site clinical structural neuroimaging studies of aging using legacy data. Neuroinformatics (2007) 1.59
Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study. BMJ (2013) 1.58
The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco. Hum Mol Genet (2007) 1.57
CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry (2006) 1.54
Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol (2010) 1.50
Association of environmental cadmium exposure with periodontal disease in U.S. adults. Environ Health Perspect (2009) 1.50
Longitudinal change in cognitive performance among individuals with mild cognitive impairment. Neuropsychology (2007) 1.49
Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol (2008) 1.48
APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol (2011) 1.47
Maternal lead exposure and the secondary sex ratio. Hum Reprod (2006) 1.44
Family-based association test for time-to-onset data with time-dependent differences between the hazard functions. Genet Epidemiol (2006) 1.43
Technologies for guidance of radiofrequency ablation in the multimodality interventional suite of the future. J Vasc Interv Radiol (2007) 1.43
Genetic association of the CHRNA6 and CHRNB3 genes with tobacco dependence in a nationally representative sample. Neuropsychopharmacology (2008) 1.42
Methodological challenges in causal research on racial and ethnic patterns of cognitive trajectories: measurement, selection, and bias. Neuropsychol Rev (2008) 1.41
Disruptive behavior as a predictor in Alzheimer disease. Arch Neurol (2007) 1.39
Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis. Arch Neurol (2012) 1.37
Family-based association tests for survival and times-to-onset analysis. Stat Med (2004) 1.35
Cadmium exposure in association with history of stroke and heart failure. Environ Res (2010) 1.35
A new multimarker test for family-based association studies. Genet Epidemiol (2007) 1.34
Seizures in Alzheimer disease: who, when, and how common? Arch Neurol (2009) 1.34
Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology (2013) 1.33
Role of disease risk scores in comparative effectiveness research with emerging therapies. Pharmacoepidemiol Drug Saf (2012) 1.32
Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke (2014) 1.32
Confounder summary scores when comparing the effects of multiple drug exposures. Pharmacoepidemiol Drug Saf (2010) 1.31
No association between CALHM1 and Alzheimer's disease risk. Cell (2008) 1.30
Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology (2012) 1.29
Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy. Ann Neurol (2012) 1.29
The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. J Gerontol A Biol Sci Med Sci (2012) 1.29
Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol (2013) 1.27
Use of di(2-ethylhexyl) phthalate-containing medical products and urinary levels of mono(2-ethylhexyl) phthalate in neonatal intensive care unit infants. Environ Health Perspect (2005) 1.27
Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke (2008) 1.26
Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2012) 1.26
Impaired medial temporal repetition suppression is related to failure of parietal deactivation in Alzheimer disease. Am J Geriatr Psychiatry (2008) 1.24
A QTL genome scan of the metabolic syndrome and its component traits. BMC Genet (2003) 1.24
Assessment of Alzheimer's disease case-control associations using family-based methods. Neurogenetics (2008) 1.23
Confounding adjustment in comparative effectiveness research conducted within distributed research networks. Med Care (2013) 1.23
Postpartum cervicocephalic artery dissection. Stroke (2008) 1.23
MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke (2010) 1.23
Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord (2014) 1.21
Availability of comparative efficacy data at the time of drug approval in the United States. JAMA (2011) 1.21
The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease. Arch Neurol (2006) 1.20
Blood lead levels and major depressive disorder, panic disorder, and generalized anxiety disorder in US young adults. Arch Gen Psychiatry (2009) 1.20
Apolipoprotein E genotype is associated with CT angiography spot sign in lobar intracerebral hemorrhage. Stroke (2012) 1.19
The effects of patient function and dependence on costs of care in Alzheimer's disease. J Am Geriatr Soc (2008) 1.19
Differential item functioning between ethnic groups in the epidemiological assessment of depression. J Nerv Ment Dis (2008) 1.16
Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community. J Am Geriatr Soc (2006) 1.16
Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease. Hum Mol Genet (2007) 1.16
Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates. Pharmacoepidemiol Drug Saf (2013) 1.15
Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe. Stroke (2009) 1.15
Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease. Alzheimer Dis Assoc Disord (2010) 1.14
CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage. Neurocrit Care (2012) 1.14